TITLE

NOTE EXPANDING ACCESS TO INVESTIGATIONAL DRUGS FOR TREATMENT USE: A POLICY ANALYSIS AND LEGISLATIVE PROPOSAL

AUTHOR(S)
Winniford, Austin
PUB. DATE
January 2009
SOURCE
Health Matrix: Journal of Law-Medicine;Winter2009, Vol. 19 Issue 1, p205
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article focuses on the new regulation of drugs investigation approved by the U.S. Food and Drug Administration (FDA). It cites the potential benefits and implications of expanding investigational drug access for medical treatment. It further highlights the strategic effort of FDA to reform its broad regulation.
ACCESSION #
39884642

 

Related Articles

  • House considering FDA reauthorization.  // Medical Device Daily;7/12/2007, Vol. 11 Issue 133, p9 

    The article focuses on the U.S. House version of the U.S. Food and Drug Administration (FDA) reauthorization bill. The House bill boosts drug safety monitoring and increased authority for the FDA to monitor the safety of drugs once they are out in the market. The Consumers Union, through its...

  • Washington letter.  // DCI;Apr95, Vol. 156 Issue 4, p8 

    Reports on the proposal from the US Congress to make easier and faster the approval process for new drugs and devices of the US Food and Drug Administration. Possible conflict of the proposal with demands from conservative groups for the strict scrutiny of new drug applications (NDA).

  • Prescription Drugs: Many Factors Affected FDA's Approval of Selected 'Pipeline' Drugs: HEHS-00-140.  // GAO Reports;8/10/2000, p1 

    The Drug Price Competition and Patent Term Restoration Act of 1984 seeks to expand the availability of more effective and affordable drugs by providing the generic drug industry with a simplified and faster review process and brand-name drug companies with an extension of the existing 17-year...

  • US Senate passes FDA Revitalization Act. Guthrie, Patricia // CMAJ: Canadian Medical Association Journal;7/3/2007, Vol. 177 Issue 1, p23 

    The article reports on the new U.S. legislation passed by the senate that would strengthen the Food and Drug Administration's (FDA) ability to scrutinize new and existing drugs. The report says the bill sponsored by Senators Edward Kennedy and Mike Enzi obligates the government to establish a...

  • FDA set to control biogenerics approvals.  // Pharmaceutical Technology Europe;Apr2007, Vol. 19 Issue 4, p13 

    The article focuses on the Access to Life-Saving Medicine Act, legislation introduced by the U.S. government that could grant the Food and Drug Administration (FDA) the authority to approve generic versions of biologics. It would enable the agency to decide which clinical trials a generics firm...

  • Backers: FDA overhaul plan won't derail biogenerics bill.  // Drug Store News;5/21/2007, Vol. 29 Issue 7, p3 

    The article reports on the bill S. 1082 or the U.S. Food & Drug Administration (FDA) Revitalization Act in strengthen public safety on drug usage in the U.S. It mentioned that the bill was passed with a vote of 93 to 1 in the U.S. House of Senate on May 9, 2007. The bill will force the FDA to...

  • FDA labors over NSAID decisions. Young, Donna // American Journal of Health-System Pharmacy;4/1/2005, Vol. 62 Issue 7, p668 

    Reports on the urge of the U.S. Food and Drug Administration (FDA) need for availability of cyclooxygenase type 2 (COX-2) in the market despite its evidence on the risk of increased cardiovascular events. Efficacy of the suggestion of the nonsteroidal antiinflammatory drugs to issue a black box...

  • Regulation looms as biggest pharma challenge. Buono, Drew // Drug Store News;5/19/2008, Vol. 30 Issue 6, p18 

    The article discusses the impact of Food and Drug Administration's (FDA) Amendment Acts of 2007 to the pharmaceutical industry in the U.S. The new rule was passed after the controversy of Merck's Vioxx in 2007. It has been important to FDA because it will give greater powers to impose additional...

  • 100 Years of FDA.  // Running & FitNews;Nov/Dec2007, Vol. 25 Issue 6, p5 

    The author reports on the U.S. Pure Food and Drug Act which became effective on January 1, 1907. According to the article, the Pure Food and Drug Act led to the U.S. Food and Drug Administration (FDA). Regulations which the Pure Food and Drug Act placed on drug manufacturers are discussed. The...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics